These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 75947

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Identification of orthopoxviruses by polyacrylamide gel electrophoresis of intracellular polypeptides. I. Four major groupings.
    Harper L, Bedson HS, Buchan A.
    Virology; 1979 Mar; 93(2):435-44. PubMed ID: 222049
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.
    Snyder JT, Belyakov IM, Dzutsev A, Lemonnier F, Berzofsky JA.
    J Virol; 2004 Jul; 78(13):7052-60. PubMed ID: 15194781
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Real-time PCR to identify variola virus or other human pathogenic orthopox viruses.
    Scaramozzino N, Ferrier-Rembert A, Favier AL, Rothlisberger C, Richard S, Crance JM, Meyer H, Garin D.
    Clin Chem; 2007 Apr; 53(4):606-13. PubMed ID: 17332145
    [Abstract] [Full Text] [Related]

  • 50. Antigenic relatedness of equine herpes virus types 1 and 3.
    Gutekunst DE, Malmquist WA, Becvar CS.
    Arch Virol; 1978 Apr; 56(1-2):33-45. PubMed ID: 75724
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Isolation and properties of the causal agent of a new variola-like disease (monkeypox) in man.
    Marennikova SS, Seluhina EM, Mal'ceva NN, Cimiskjan KL, Macevic GR.
    Bull World Health Organ; 1972 Apr; 46(5):599-611. PubMed ID: 4340219
    [Abstract] [Full Text] [Related]

  • 53. [SOLUBLE "POX VIRUS" ANTIGENS. I. STUDY OF SMALLPOX AND VACCINIA VIRUS SOLUBLE ANTIGENS].
    NICOLI J, JOLIBOIS C.
    Ann Inst Pasteur (Paris); 1964 Sep; 107():374-83. PubMed ID: 14190395
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Differential inhibitory effects of 5-bromodeoxyuridine on vaccinia and monkeypox viruses.
    Yoshii T, Kono R.
    J Hyg (Lond); 1978 Oct; 81(2):171-7. PubMed ID: 212474
    [Abstract] [Full Text] [Related]

  • 58. Monoclonal antibodies to monkey pox virus: preparation and application.
    Marennikova SS, Nagieva FG, Matsevich GR, Shelukhina EM, Khabakhpasheva AA, Platonova GM.
    Acta Virol; 1988 Jan; 32(1):19-26. PubMed ID: 2897768
    [Abstract] [Full Text] [Related]

  • 59. Interference between vaccinia and variola viruses in chick embryos.
    Bektemirov TA.
    Acta Virol; 1965 Nov; 9(6):546-50. PubMed ID: 4379439
    [No Abstract] [Full Text] [Related]

  • 60. Orthopoxvirus DNA: a comparison of restriction profiles and maps.
    Esposito JJ, Knight JC.
    Virology; 1985 May; 143(1):230-51. PubMed ID: 2998003
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.